Axis adds Swiss distribution arm

Axis-Shield plc, an in-vitro diagnostics (IVD) company, has acquired a Swiss distribution channel for its point-of-care (PoC) IVD products from Nycomed Pharma AG (NPAG), the Swiss sales subsidiary of Nycomed.


Axis-Shield plc, an in-vitro diagnostics (IVD) company, has acquired a Swiss distribution channel for its point-of-care (PoC) IVD products from Nycomed Pharma AG (NPAG), the Swiss sales subsidiary of Nycomed.

Axis-Shield plc, an in-vitro diagnostics (IVD) company, has acquired a Swiss distribution channel for its point-of-care (PoC) IVD products from Nycomed Pharma AG (NPAG), the Swiss sales subsidiary of Nycomed.

Axis-Shield will assume the distribution of Axis-Shield PoC products from 1 January 2008.

Svein Lien, Axis-Shield’s chief executive officer, commented: “The acquisition of this PoC distribution business in Switzerland is earnings enhancing for Axis-Shield and complements our existing European direct sale capabilities in the UK and the Nordic countries.”

Switzerland is a key market for PoC IVD products and is Axis-Shield’s largest export market in PoC at this time.

Marc Barber

Raven Connelly

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics

Venture capital funding